Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs111365677
rs111365677 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112106319
rs112106319
TNC ; DELEC1
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs112538845
rs112538845 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs11924809
rs11924809
DGKG
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142484554
rs142484554
SPSB4
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs142641502
rs142641502
CSTF3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143405544
rs143405544
ADAMTS6
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs143934587
rs143934587 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1548076
rs1548076 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs16875288
rs16875288
ADAMTS16 ; LOC101929200
0.700 GeneticVariation GWASCAT Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia. 24039173

2013
dbSNP: rs182377406
rs182377406 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183042538
rs183042538
ZHX3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183124483
rs183124483
NLK
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs188843168
rs188843168
ATP5MD
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs189864513
rs189864513
LINC01618
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs190783615
rs190783615 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs200855945
rs200855945
SSPN ; BHLHE41
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs201203751
rs201203751
FYB1
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs201569130
rs201569130 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs201921722
rs201921722 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs34102224
rs34102224 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs34177316
rs34177316
APBB2 ; LOC107986273
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs4685959
rs4685959 		0.700 GeneticVariation GWASCAT Genome-wide association studies of placebo and duloxetine response in major depressive disorder. 28696415

2018
dbSNP: rs4839421
rs4839421
CYMP
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs56388524
rs56388524 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016